Nebius Q3 Results Beat Expectations, CapEx Raised to $27B, ARR Target Delayed; Shares Fall Over 14% in Pre-Market | Financial News
Nebius reported Q3 revenue of $981 million (up 571% year-over-year) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company postponed and narrowed its annualized recurring…
Nebius reported Q3 revenue of $981 million (up 571% year-over-year) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company postponed and narrowed its annualized recurring revenue (ARR) guidance, stating it was no longer applicable, while significantly raising its 2026 capital expenditure to $27 billion and projecting a further increase to $40-45 billion in 2027. Shares plunged over 14% in pre-market trading.
Original: https://wallstreetcn.com/articles/3785826
insigtX content is informational and educational, not investment advice.